SCHEMBL2197048

SCHEMBL2197048

c1ccc(OCc2ccc(C(OC3CCOCC3)c3cc4cccnc4[nH]3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GCK P35557 14/20 0.48
PRMT5 O14744 3/20 0.39
PARP14 Q460N5 1/20 0.35
RIPK1 Q13546 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2196374 0.79 GCK (0.51) GCK
SCHEMBL2198514 0.76 GCK (0.50) GCK
SCHEMBL2280345 0.75 GCK (0.47) GCK
SCHEMBL2280341 0.75 GCK (0.47) GCK
SCHEMBL2198311 0.71 GCK (0.60) GCK
SCHEMBL2195743 0.69 GCK (0.42) GCK
SCHEMBL2180542 0.66 GCK (0.45) GCK
SCHEMBL1960386 0.65 GCK (0.62) GCK
SCHEMBL2180026 0.65 GCK (0.48) GCK
SCHEMBL2177573 0.64 GCK (0.43) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011080755-A1 FUSED NITROGEN HETEROCYCLIC COMPOUNDS, PROCESS OF PREPARATION AND USES THEREOF ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-07-07 WO disclosed